As used in this article, the following terms shall have the meanings indicated:
MARIJUANAAll parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; and resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. It does not include the mature stalks of the plant, fiber produced from the stalks, oil, or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks, except the resin extracted from, fiber, oil, or cake or the sterilized seed of the plant which is incapable of germination. Marijuana also includes marijuana-infused products (MIPs) except where the context clearly indicates otherwise.
MARIJUANA-INFUSED PRODUCT (MIP)A product infused with marijuana that is intended for use or consumption, including but not limited to edible products, ointments, aerosols, oils, and tinctures. These products, when created or sold by an RMD, shall not be considered a food or a drug as defined in MGL c. 94, § 1.
MEDICAL MARIJUANA TREATMENT CENTERA not-for-profit entity registered under 105 CMR 725.00, to be known as a "registered marijuana dispensary (RMD)," that acquires, cultivates, possesses, processes (including development of related products such as edible MIPs, tinctures, aerosols, oils, or ointments), transfers, transports, sells, distributes, dispenses, or administers marijuana, products containing marijuana, related supplies, or educational materials to registered qualifying patients or their personal caregivers, as those terms are defined under 105 CMR 725.004. Unless otherwise specified, "RMD" refers to the site(s) of dispensing, cultivating, and preparation of marijuana.
MEDICAL USE OF MARIJUANAThe acquisition, cultivation, possession, processing (including development of related products such as tinctures, aerosols, or ointments), transfer, transportation, sale, distribution, dispensing, or administration of marijuana, for the benefit of qualifying patients in the treatment of debilitating medical conditions, or the symptoms thereof, as those terms are defined under 105 CMR 725.004.